Similar articles

• [Drug interactions: new mechanisms and clinical relevance].

  Paneitz A, Meissner K, Kroemer HK. Paneitz A, et al. Internist (Berl). 2000 Apr;41(4):338-43. doi: 10.1007/s001080050515. Internist (Berl). 2000. PMID: 10798181 Review. German. No abstract available.
• Pharmacogenetics approach to therapeutics.

  Koo SH, Lee EJ. Koo SH, et al. Clin Exp Pharmacol Physiol. 2006 May-Jun;33(5-6):525-32. doi: 10.1111/j.1440-1681.2006.04402.x. Clin Exp Pharmacol Physiol. 2006. PMID: 16700889 Review.
• Pharmacogenetics of CYP enzymes and drug transporters: remarkable recent advances.

  Kim RB. Kim RB. Adv Drug Deliv Rev. 2002 Nov 18;54(10):1241-2. doi: 10.1016/s0169-409x(02)00167-9. Adv Drug Deliv Rev. 2002. PMID: 12406641 Review. No abstract available.
• Drug transporters in drug efficacy and toxicity.

  DeGorter MK, Xia CQ, Yang JJ, Kim RB. DeGorter MK, et al. Annu Rev Pharmacol Toxicol. 2012;52:249-73. doi: 10.1146/annurev-pharmtox-010611-134529. Epub 2011 Sep 19. Annu Rev Pharmacol Toxicol. 2012. PMID: 21942630 Review.
• Pharmacogenetics of the cytochromes P450.

  Daly AK. Daly AK. Curr Top Med Chem. 2004;4(16):1733-44. doi: 10.2174/1568026043387070. Curr Top Med Chem. 2004. PMID: 15579105 Review.